This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Clinical Trial

. 1975 Oct;20(10):971-6.

doi: 10.1007/BF01070886.

Salicylazosulfapyridine in inflammatory bowel disease

K M Das, I Sternlieb

PMID: 242212
DOI: 10.1007/BF01070886

Clinical Trial

Salicylazosulfapyridine in inflammatory bowel disease

K M Das et al. Am J Dig Dis. 1975 Oct.

. 1975 Oct;20(10):971-6.

doi: 10.1007/BF01070886.

Authors

K M Das, I Sternlieb

PMID: 242212
DOI: 10.1007/BF01070886

No abstract available

PubMed Disclaimer

Similar articles

Salicylazosulfapyridine in clinical practice.
Goldman P, Peppercorn MA. Goldman P, et al. Gastroenterology. 1973 Jul;65(1):166-9. Gastroenterology. 1973. PMID: 4146457 No abstract available.
Amelioration of dextran sulfate sodium-induced chronic colitis by sulfasalazine salicylazosulfapyridine via reducing NF-kappaB transcription factor p65 recruitment to ICAM-1 gene promoters.
Zhao W, Song L, Hongzhu D. Zhao W, et al. Yakugaku Zasshi. 2010 Sep;130(9):1239-49. doi: 10.1248/yakushi.130.1239. Yakugaku Zasshi. 2010. PMID: 20823682
[Therapy of radiogenic colitis with salicylazosulfapyridine (azulfidine)].
Rauch K, Weiland H. Rauch K, et al. Strahlentherapie. 1972 Jun;143(6):660-3. Strahlentherapie. 1972. PMID: 4403660 German. No abstract available.
Sulfasalazine and 5-ASA compounds.
Allgayer H. Allgayer H. Gastroenterol Clin North Am. 1992 Sep;21(3):643-58. Gastroenterol Clin North Am. 1992. PMID: 1355468 Review.
Drug therapy of inflammatory bowel disease.
Sack DM, Peppercorn MA. Sack DM, et al. Pharmacotherapy. 1983 May-Jun;3(3):158-76. doi: 10.1002/j.1875-9114.1983.tb03245.x. Pharmacotherapy. 1983. PMID: 6136027 Review.

See all similar articles

Cited by

Comparative tolerability of therapies for ulcerative colitis.
Ardizzone S, Bianchi Porro G. Ardizzone S, et al. Drug Saf. 2002;25(8):561-82. doi: 10.2165/00002018-200225080-00003. Drug Saf. 2002. PMID: 12113642 Review.
Amino acid derivatives of 5-ASA as novel prodrugs for intestinal drug delivery.
Clerici C, Gentili G, Boschetti E, Santucci C, Aburbeh AG, Natalini B, Pellicciari R, Morelli A. Clerici C, et al. Dig Dis Sci. 1994 Dec;39(12):2601-6. doi: 10.1007/BF02087696. Dig Dis Sci. 1994. PMID: 7995185
Crohn disease. Newer aspects of etiology, diagnosis and therapy.
[No authors listed] [No authors listed] West J Med. 1978 May;128(5):419-27. West J Med. 1978. PMID: 664644 Free PMC article. No abstract available.

References

1. N Engl J Med. 1973 Sep 6;289(10):491-5 - PubMed
1. Gastroenterology. 1968 Apr;54(4):575-87 - PubMed
1. Acta Med Scand. 1963 Jan;173:61-72 - PubMed
1. Br Med J. 1962 Dec 29;2(5321):1708-11 - PubMed
1. Scand J Gastroenterol. 1973;8(1):71-4 - PubMed

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Other Literature Sources
- The Lens - Patent Citations Database